"10.1371_journal.pone.0114745","plos one","2014-12-05T00:00:00Z","Ritesh Agarwal; David W Denning; Arunaloke Chakrabarti","Department of Pulmonary Medicine, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India; National Aspergillosis Centre, University Hospital of South Manchester, University of Manchester, Manchester Academic Health Science Centre, 2nd Floor Education & Research Centre, University of Manchester, Manchester, M23 9LT, United Kingdom; Department of Medical Microbiology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India","Conceived and designed the experiments: RA DWD AC. Performed the experiments: RA DWD AC. Analyzed the data: RA DWD AC. Contributed reagents/materials/analysis tools: RA DWD AC. Wrote the paper: RA DWD AC.","Dr. Denning holds founder shares in F2G Ltd a University of Manchester spin-out company and has current grant support from the National Institute of Allergy and Infectious Diseases, National Institute of Health Research, the European Union and AstraZeneca. He acts as a consultant to Trinity group, T2 Biosystems, GSK, as well as other companies over the last 5 years including Pfizer, Schering Plough (now Merck), Astellas and Gilead. In the last 3 years, he has been paid for talks on behalf of Astellas, GSK, Gilead and Pfizer. The other authors have no competing interests to report. The competing interests do not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2014","12","Ritesh Agarwal","RA",3,FALSE,3,3,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
